Effect on in vivo tumorigenicity of lengthy exposure of human colon cancer cells to the differentiation agent hexamethylene bisacetamide
- 1 November 1989
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 48 (1) , 53-58
- https://doi.org/10.1016/0304-3835(89)90202-4
Abstract
No abstract availableKeywords
This publication has 4 references indexed in Scilit:
- PHASE-I TRIAL AND CLINICAL PHARMACOLOGICAL EVALUATION OF HEXAMETHYLENE BISACETAMIDE ADMINISTRATION BY 10-DAY CONTINUOUS INTRAVENOUS-INFUSION AT 28-DAY INTERVALS1988
- Absorptive and mucus-secreting subclones isolated from a multipotent intestinal cell line (HT-29) provide new models for cell polarity and terminal differentiation.The Journal of cell biology, 1987
- Enterocytic differentiation of a subpopulation of the human colon tumor cell line HT‐29 selected for growth in sugar‐free medium and its inhibition by glucoseJournal of Cellular Physiology, 1985
- EMERGENCE OF PERMANENTLY DIFFERENTIATED CELL CLONES IN A HUMAN COLONIC-CANCER CELL-LINE IN CULTURE AFTER TREATMENT WITH SODIUM-BUTYRATE1984